Atara Biotherapeutics

two arrows pointing different directions
Favicon Fierce Pharma

FDA to reconsider rejected cell therapy. Could uniQure be next?

As the FDA walks back its previous criticism of Ebvallo's single-arm trial, there's hope for a reversal for uniQure's gene therapy, too.
Angus Liu May 7, 2026 10:40am
Conceptual illustration of layoffs featuring rows of translucent human figures overlaid with large blue scissors symbolizing

Biopharma layoffs hit 4-year monthly high in May

Jul 8, 2025 2:26pm
team layoffs workforce

Atara lays off more staff despite FDA lifting clinical hold

May 13, 2025 10:07am
A series of dice with a bag on them illustrating cost cuts

Atara, reeling from FDA hold on Ebvallo, halves workforce

Mar 4, 2025 8:07am
picture of a paraglider

CRISPR-focused Caribou christens new CMO—Chutes & Ladders

Aug 16, 2024 8:30am
photo of parachutes over a river

Ex-Eisai leader to be new NextPoint CEO—Chutes & Ladders

Feb 2, 2024 9:30am